Sofosbuvir (Sovaldi) for hepatitis C virus

Nurse Pract. 2015 Sep 13;40(9):16-9. doi: 10.1097/01.NPR.0000470360.31332.54.
No abstract available

Publication types

  • News

MeSH terms

  • Antiviral Agents / pharmacokinetics
  • Antiviral Agents / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Drug Approval*
  • Hepacivirus / genetics
  • Hepatitis C / drug therapy*
  • Humans
  • Sofosbuvir
  • United States
  • United States Food and Drug Administration
  • Uridine Monophosphate / analogs & derivatives*
  • Uridine Monophosphate / pharmacokinetics
  • Uridine Monophosphate / therapeutic use

Substances

  • Antiviral Agents
  • Uridine Monophosphate
  • Sofosbuvir